Effectiveness of pregabalin as an adjuvant therapy for chronic nonbacterial prostatitis

Trial Profile

Effectiveness of pregabalin as an adjuvant therapy for chronic nonbacterial prostatitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2016

At a glance

  • Drugs Pregabalin (Primary) ; Terazosin (Primary)
  • Indications Prostatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2016 The date given in the bundle is Expected recruitment end date, not trial end date so can not be added.
    • 21 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top